COVID-19 Research And Innovation

The Center for Technology Transfer and Commercialization continued to play a pivotal role in translating the research findings of Vanderbilt faculty into products and companies in 2020 that have the potential to transform many aspects of life, from disease prevention to quality of life-enhancing products. Read More

The Vanderbilt Kennedy Center will host a Research Ethics Grand Rounds panel discussion, "Standards of Care, Disability and a Public Health Emergency: Conversations on Equitable Care during COVID-19," on Wednesday, May 19, from noon to 1 p.m. CT. Read More

Dr. James E. Crowe Jr., a physician-scientist on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt University’s winner of the 2021 Southeastern Conference Faculty Achievement Award. Read More

Vanderbilt’s role in shaping each step of the medical response to the COVID-19 pandemic began three decades ago and is grounded in the determination of a small group of scientists to understand coronaviruses. The research, and the faculty and alumni who helped lead it, was the topic of the March 23 Chancellor’s Lecture Series virtual event, “Vanderbilt in the Vanguard: The Decades-Long Journey to a Coronavirus Vaccine.” Read More

The remarkable success of the COVID-19 vaccines began in a Vanderbilt lab decades ago, with the groundbreaking research of alumnus Dr. Barney Graham. Read More

Vanderbilt scientists on the front lines of COVID-19 research will share their insights on the pandemic and subsequent vaccine development during a Chancellor’s Lecture Series event on Tuesday, March 23, at 5 p.m. CT, hosted by Chancellor Daniel Diermeier. Read More

During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of Peabody College's James Booth and the College of Arts and Science's Katherine Friedman are highlighted. Read More

Christina D. Romer, the Class of 1957-Garff B. Wilson Professor of Economics at the University of California–Berkeley, will discuss “The Macroeconomic Policy Response to the Pandemic: The Good, the Bad and the Ugly” on Tuesday, March 9, beginning at 4 p.m. CT. Her virtual talk is the spring 2021 McGee Public Policy Lecture sponsored by the Department of Economics. Read More

During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. The efforts of the School of Medicine Basic Science's Danny Winder and the School ofEngineering's Ethan Lippmann are highlighted. Read More

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read More

In January 2020, the accelerating spread of SARS-CoV-2 made it apparent that VUMC’s two-bed Contagious Disease Response Unit, created for the rare victim of Ebola or other more-isolated emerging pathogen, would not suffice if Nashville were to be hit hard. So administrators began planning for a major outbreak. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

The Vanderbilt Diabetes Center, the NIH-funded Diabetes Research and Training Center, and the NIH-funded Center for Diabetes Translational Research seek pilot and feasibility proposals to study the interaction of SARS-CoV-2/COVID-19 and diabetes. Read More

One of the world’s foremost experts on coronaviruses, Dr. Mark R. Denison, shared his research and insights into COVID-19 during a webinar on Dec. 14. A video of the webinar is now available for viewing. Read More

Chancellor Daniel Diermeier will host a special presentation with coronavirus expert Dr. Mark R. Denison on Monday, Dec. 14, from 11 a.m. to noon Central time. Denison’s presentation, “Preparing for the COVID-19 Pandemic ... for 36 Years,” will explore why COVID-19 emerged, his lab’s discoveries, and where we go from here. Read More

Understanding the function of host cells when infected with SARS-CoV-2 may lead to host-directed antiviral therapeutics. Read More

Since the beginning of June, Peabody College professor Ann Kaiser and her team have been assessing the language development of toddlers over Zoom, discovering not only that virtual intervention works, but also that, in many ways, it may have unique benefits when compared to in-person intervention. Read More

When in-person research activities at Vanderbilt were put on hold in mid-March due to the COVID-19 pandemic, nursing professor Sheila Ridner’s steadfast commitment to patients ensured that their care did not suffer. Read More

Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read More

Erin Calipari, assistant professor of pharmacology and of psychiatry and behavioral sciences, discusses the COVID-19 pandemic's impact on those struggling with opioid addiction. Read More